1.
Interplay between genetic predisposition, macronutrient intake and type 2 diabetes incidence : analysis within EPIC-InterAct across eight European countries
by Li, Sherly X
Diabetologia, 2018-06-01, Vol.61 (6), p.1325-1332
2.
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities
by Brunkwall, Louise
Diabetologia, 2017-04-22, Vol.60 (6), p.943-951
3.
The many faces of diabetes: a disease with increasing heterogeneity
by Tuomi, Tiinamaija, MD
The Lancet (British edition), 2014, Vol.383 (9922), p.1084-1094
4.
Genetic risk factors for type 1 diabetes
by Pociot, Flemming, Prof
The Lancet (British edition), 2016, Vol.387 (10035), p.2331-2339
5.
Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment
by Leslie, R. David
Diabetologia, 2015-10-24, Vol.59 (1), p.13-20
6.
7.
Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study
by Eriksson, Jan W
Diabetologia, 2018-07-03, Vol.61 (9), p.1923-1934
8.
Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants
by Lu, Y
The Lancet (British edition), 2016-04-09, Vol.387 (10027), p.1513-1530
9.
Environmental risk factors for type 1 diabetes
by Rewers, Marian, Prof
The Lancet (British edition), 2016, Vol.387 (10035), p.2340-2348
10.
β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment
by Halban, Philippe A
The journal of clinical endocrinology and metabolism, 2014-06, Vol.99 (6), p.1983
11.
Aberrant intestinal microbiota in individuals with prediabetes
by Allin, Kristine H
Diabetologia, 2018-01-29, Vol.61 (4), p.810-820
12.
Prospective virome analyses in young children at increased genetic risk for type 1 diabetes
by Vehik, Kendra
Nature medicine, 2019-12, Vol.25 (12), p.1865-1872
13.
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study
by Krischer, Jeffrey P
Diabetologia, 2015-02-10, Vol.58 (5), p.980-987
14.
Early prediction of autoimmune (type 1) diabetes
by Regnell, Simon E
Diabetologia, 2017-05-26, Vol.60 (8), p.1370-1381
15.
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
by Dunne, Jessica L
Diabetologia, 2019-01-23, Vol.62 (5), p.744-753
16.
Overweight, obesity and the risk of LADA: results from a Swedish case–control study and the Norwegian HUNT Study
by Hjort, Rebecka
Diabetologia, 2018-03-27, Vol.61 (6), p.1333-1343
17.
Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals
by Carstensen, Bendix
Diabetologia, 2016-02-29, Vol.59 (5), p.980-988
18.
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Si...
by Pavel, M
Neuroendocrinology, 2016-04, Vol.103 (2), p.172-185
19.
A Major Lineage of Enteroendocrine Cells Coexpress CCK, Secretin, GIP, GLP-1, PYY, and Neurotensin but Not Somatostatin
by Egerod, Kristoffer L
Endocrinology (Philadelphia), 2012-12, Vol.153 (12), p.5782-5795
20.
Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 200...
by Norhammar, Anna
Diabetologia, 2016-05-18, Vol.59 (8), p.1692-1701
